FDA Withdraws Approval For Ukoniq Cancer Drug Due To Possible Death Risk

SILVER SPRING, Md. — The Food and Drug Administration on June 1 said it has withdrawn its approval for the cancer drug Ukoniq after updated clinical trial results continued to show...

Already a subscriber? Click here to view full article